Global varicose veins treatment devices market, based on the treatment was segmented into injection sclerotherapy, endovenous ablation, and surgical ligation market. In 2017, the endovenous ablation segment held the largest share of the market, by treatment. However, on the basis of growth rate, the sclerotherapy segment is expected to witness the fastest growth rate among the treatment segment in the global varicose veins treatment devices market as the ultrasound based foam sclerotherapy is a relatively new technique that is minimally invasive and offers several advantages minimizing patient discomfort.
Until recently, the only effective and lasting surgical treatment for varicose veins of legs was the ligation of saphenous femoral arch along with stripping of the great saphenous vein. Over the latest decade, technological progress has enabled the development and application of new minimally invasive therapies such as VNUS Closure endovenous radiofrequency ablation (RFA) and endolaser to the treat the medical condition.
Get Sample Copy Of This [email protected] https://www.theinsightpartners.com/sample/TIPHE100001235/
The global varicose veins treatment devices market is expected to reach US$ 1,032.4 Mn in 2025 from US$ 512.6 Mn in 2017. The market is estimated to grow with a CAGR of 9.6% from 2018-2025. The report highlights the trends prevalent in the global varicose veins treatment devices market and the factors driving the market along with those that act as restraints to its growth. The global varicose veins treatment devices market is witnessing a sheer rise in the current scenario and is expected to expand in the coming years.
The major players operating in the varicose veins treatment devices market include Alma Lasers, AngioDynamics, VVT Med, F care systems, Asclepion Laser Technologies GmbH, Syneron Medical Ltd., Energist Ltd., Medtronic, biolitec AG, and Miravas among others. The launch of novel and innovative solutions by market players also have led to striking new introductions in the market as a result of which the global varicose veins treatment devices market is likely to grow. For instance, in November 2015, Medtronic introduced the VenaSeal closure system in the US that incorporates a novel technology for patient relief with varicose veins.
In the recent years various new improvements have evolved treatments available for varicose veins with the introduction of minimally invasive therapies such as sclerotherapy and ablation techniques. These techniques have recently been introduced to be valid alternate options to the conventional surgical procedures for the treatment of varicose veins. According to a study conducted by National Institute of Health and published in 2016, a trend towards a less invasive approach for the treatment of varicose veins, with safe and effective results was observed as a part of the retrospective analysis conducted among 350+ patients from September 2013 to July 2015.